New Delhi, May 13 -- US President Donald Trump has decided to slash the prices of prescription drugs in the country by 59% through an executive order. As per his plan, the US will pay the same price for a prescription drug as the nation that pays the lowest price for that drug anywhere in the world. What does this mean for Indian pharmaceutical companies, which count the US as their largest market?

For now, experts are unsure of the potential impact of Trump's decision on Indian drug exporters, who mostly ship relatively inexpensive generic drugs to the US. But they acknowledged that Trump's latest decision adds to the volatility already injected by his looming threat of additional tariffs on India's drug exports to the US.

Mintdecodes ...